Design and development of PEGylated liposomal formulation of HER2 blocker Lapatinib for enhanced anticancer activity

Richa Shrivastava1, Shruti Trivedi2, Pankaj Kumar Singh3

  • 1Division of Toxicology and Experimental Medicine, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, 226031, India; Academy of Scientific and Innovative Research, (AcSIR), New Delhi, 110025, India.

Insights

This study developed PEGylated liposomal Lapatinib to improve breast cancer treatment. The new formulation enhanced anti-tumor effects and reduced cardiotoxicity compared to free Lapatinib.

Area of Science:

  • Oncology
  • Nanotechnology
  • Pharmacology

Background:

  • Breast cancer is a leading cause of death in women, with HER2/neu receptor overexpression in 20-30% of cases.
  • Lapatinib, a dual tyrosine kinase inhibitor, targets EGFR and HER2 but faces clinical limitations due to poor solubility (Class II BSC) and cardiotoxicity.
  • HER2 receptors on cardiomyocytes contribute to Lapatinib-induced cardiotoxicity.

Purpose of the Study:

  • To design and characterize a PEGylated liposomal formulation of Lapatinib.
  • To evaluate the enhanced anticancer potential and reduced cardiotoxicity of this novel formulation.
  • To investigate the anti-tumor mechanisms, including apoptosis induction.

Main Methods:

  • Lapatinib liposomes were prepared using the lipid layer hydration method.
  • Formulation characterization included particle size, zeta potential, entrapment efficiency, and in vitro release profiling.
  • Anticancer efficacy and cardiotoxicity were assessed in chick embryo xenograft models (MDA-MB-453 cells), with flow cytometry and immunofluorescence used for apoptosis analysis.

Main Results:

  • PEGylated liposomal Lapatinib significantly reduced tumor size compared to free Lapatinib.
  • Enhanced apoptotic potential was confirmed via flow cytometry and cleaved PARP antibody staining.
  • Serum SGOT levels, a marker for cardiotoxicity and hepatotoxicity, were significantly decreased in the liposomal Lapatinib group.

Conclusions:

  • PEGylated liposomal Lapatinib demonstrates enhanced anti-tumor activity and reduced cardiotoxicity.
  • This formulation represents a promising therapeutic strategy for HER2-positive breast cancer.
  • It can be used as a standalone treatment or in combination with other therapies.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Group Design02:01

Group Design

The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.7K
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
610
Factorial Design02:01

Factorial Design

Factorial Analysis is an experimental design that applies Analysis of Variance (ANOVA) statistical procedures to examine a change in a dependent variable due to more than one independent variable, also known as factors. Changes in worker productivity can be reasoned, for example, to be influenced by salary and other conditions, such as skill level. One way to test this hypothesis is by categorizing salary into three levels (low, moderate, and high) and skills sets into two levels (entry level...
14.0K
Self-Evaluation: Self-Enhancement and Self-Verification03:00

Self-Evaluation: Self-Enhancement and Self-Verification

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K
Cartesian Form for Vector Formulation01:26

Cartesian Form for Vector Formulation

The Cartesian form for vector formulation is a process to calculate  the moment of force using the position and force vectors. The moment of force is defined as the cross-product of these vectors, making it a vector quantity. The Cartesian form of the position and force vectors involves unit vectors, which can be used to express the cross-product in determinant form.
1.1K